PMGC Holdings (ELAB) Price/OCF Ratio: History & Chart

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T13:36:27.554Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:27.554Z.

Quote observation: 2026-10-06T13:34:34.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,413,106
TTM operating cash flow · period ending 2026-06-30: N/A

FMP input reference: ec04a23f2eccb1c46d806cafb3c6508f31619b4012dc27c85b71ebd533873098

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

ELAB Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

ELAB Competitors' Price/OCF Ratio

ELAB

PMGC Holdings Inc.

Current

Market Cap

$1.41M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs ELAB

Market Cap

$1.40M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs ELAB

Market Cap

$1.38M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IVF

INVO Fertility, Inc.

vs ELAB

Market Cap

$1.45M

Price/OCF Ratio

N/A

TTM Avg

7.82

3Y Avg

7.82

5Y Avg

7.82

CRIS

Curis, Inc.

vs ELAB

Market Cap

$1.47M

Price/OCF Ratio

N/A

TTM Avg

56.34

3Y Avg

56.34

5Y Avg

56.34

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs ELAB

Market Cap

$1.50M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMCC

IM Cannabis Corp.

vs ELAB

Market Cap

$1.17M

Price/OCF Ratio

N/A

TTM Avg

2.88

3Y Avg

2.62

5Y Avg

2.62

JUNS

Jupiter Neurosciences, Inc.

vs ELAB

Market Cap

$1.15M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HKPD

Cellyan Biotechnology Co., Ltd

vs ELAB

Market Cap

$1.14M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CMND

Clearmind Medicine Inc.

vs ELAB

Market Cap

$1.08M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
PMGC Holdings Inc. (ELAB)	$1.41M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.40M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.38M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.45M	N/A	7.82	7.82	7.82
Curis, Inc. (CRIS)vs ›	$1.47M	N/A	56.34	56.34	56.34
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.50M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.17M	N/A	2.88	2.62	2.62
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.15M	N/A	N/A	N/A	N/A
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.14M	N/A	N/A	N/A	N/A
Clearmind Medicine Inc. (CMND)vs ›	$1.08M	N/A	N/A	N/A	N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

ELAB Price/OCF Ratio Metrics

ELAB Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics